Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Authors
Ndjeka, NConradie, F
Meintjes, G
Reuter, A
Hughes, J
Padanilam, X
Ismail, N
Kock, Y
Master, I
Romero, R
Te Riele, J
Enwerem, M
Ferreira, H
Maartens, G
Issue Date
2020-07-23Submitted date
2020-10-06
Metadata
Show full item recordJournal
The European Respiratory JournalAbstract
Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partnership and collaboration, could strengthen the fight against COVID-19Publisher
European Respiratory SocietyPubMed ID
32471936Type
OtherLanguage
enEISSN
1399-3003ae974a485f413a2113503eed53cd6c53
10.1183/13993003.01369-2020
Scopus Count
Collections
Related articles
- COVID-19 and tuberculosis in South Africa: A dangerous combination.
- Authors: Boffa J, Mhlaba T, Sulis G, Moyo S, Sifumba Z, Pai M, Daftary A
- Issue date: 2020 Mar 27
- Challenges around COVID-19 at a tertiary-level healthcare facility in South Africa and strategies implemented for improvement.
- Authors: Thomas T, Laher AE, Mahomed A, Stacey S, Motara F, Mer M
- Issue date: 2020 Aug 19
- Reactivation of SARS-CoV-2 after recovery.
- Authors: Yoo SY, Lee Y, Lee GH, Kim DH
- Issue date: 2020 Jul
- Intuitive Global Insight Into COVID-19 Clinical Research Activities-The "COVID-19 Map of Hope".
- Authors: Ries M, Mechler K, Smith DL, Herfort B, Visintini J, Santana AV, Zipf A, Lautenbach S
- Issue date: 2020 Jul
- Diagnosis and Management of COVID-19 Disease.
- Authors: Jamil S, Mark N, Carlos G, Cruz CSD, Gross JE, Pasnick S
- Issue date: 2020 May 15